PB1934: REAL-WORLD OUTCOMES OF ECULIZUMAB TREATMENT IN PATIENTS WITH PAROXYSMAL NOCTURNAL HEMOGLOBINUREA: A SYSTEMATIC LITERATURE REVIEW AND EVIDENCE SYNTHESIS

• J.-I. Nishimura,
• E. Popoff,
• A. Cheung,
• A. Wang,
• I. Tomazos,
• J. Szer

Affiliations

J.-I. Nishimura

1 Osaka University Graduate School of Medicine, Suita, Japan

E. Popoff

2 Broadstreet HEOR, Vancouver, BC, Canada

A. Cheung

2 Broadstreet HEOR, Vancouver, BC, Canada

A. Wang

3 Alexion, AstraZeneca Rare Disease, Boston, MA, United States of America

I. Tomazos

3 Alexion, AstraZeneca Rare Disease, Boston, MA, United States of America

J. Szer

4 Peter MacCallum Cancer Centre and The Royal Melbourne Hospital, Melbourne, VIC, Australia